This Week in Startups

Next Unicorns: Developing drugs to extend dog lifespans with Loyal CEO Celine Halioua | E1799

4 snips
Aug 30, 2023
Celine Halioua, CEO and founder of Loyal, explores groundbreaking ways to extend dog lifespans through innovative drug developments. With her background in neuroscience, she discusses the benefits of canine-specific medications and the parallels between dog and human aging. The episode delves into the challenges of developing effective treatments while addressing genetic issues stemming from selective breeding. Celine also shares insights on the ethics of veterinary research and the critical role of continued advancements in pet health for overall well-being.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Loyal's Origin

  • Celine Halioua switched from art school to neuroscience after realizing adults couldn't solve age-related diseases.
  • Inspired by the link between dog size and lifespan, she started Loyal, a company focused on dog life extension.
INSIGHT

Why Dogs?

  • Dogs share environments with humans, making them good models for human aging.
  • They experience similar age-related diseases and environmental factors, making them better than chimpanzees for studying human aging.
INSIGHT

Shared Diseases

  • Dogs and humans share many age-related diseases, except cardiovascular issues.
  • This difference is likely due to environmental factors like diet and smoking.
Get the Snipd Podcast app to discover more snips from this episode
Get the app